atHeart Medical, today announced the appointment of Andrew Cleeland to the company’s Board of Directors.
Fabien’s successful track record in medical device development is the result of a forward-thinking mindset and strategic technical planning.
Fabien joined atHeart Medical as Vice President R&D in March 2023, leading the team driving forward the atHeart Medical R&D for next generation devices.
Fabien boasts a comprehensive 20-year background in project management, spanning across various facets from materials to the development of products. Prior to atHeart Medical, Fabien held leadership roles at startups in structural heart devices and biomaterials, including Symetis (acquired by Boston Scientific), Foldax (polymeric heart valve) and Open Stent Solutions (transcatheter mitral valve). In addition, Fabien’s career extended to well established companies such as Vascutek/Terumo and Datascope. His professional journey has taken him to multiple European countries, Australia and the United States.
A Mechanical Engineer graduate from University of Toulon, France and from University of West Scotland in Paisley, UK, Fabien gained his master’s degree in Polymer Science at University of North London, UK. He is main inventor or co-inventor of 15 patents granted between 2016 and 2022.
Scott is a veteran regulatory affairs executive with a proven track record in successful global regulatory strategies.
Alex’s broad range of expertise in operations and operations quality results from 30 years in the cardiac and cardiovascular medtech industry.
Alexander is Vice-President of Operations at atHeart Medical since May 2022. He has been with the company in a consulting role since it began operations in 2020.
With a drive for accomplishments and a strong compliance attitude, Alex has a remarkable experience spanning from manufacturing to clinical project management, from sales and business development to quality assurance.
Alex previously worked in-house at major corporations, such as Abbott and Guidant, and at start-up companies such as Xeltis. More recently, he also worked in the medtech industry as a consultant.
Alexander holds a biomedical engineering degree from Technical University Ulm, Germany.
Maureen’s expertise is setting up quality systems for successful start-up organizations.
Maureen is Vice-President of Quality for atHeart Medical since April 2022. She joined the company, bringing over twenty years of distinguished quality experience in multiple, prominent cardiovascular medical device start-ups such as Twelve and Ardian.
She has previously worked both in-house and as a consultant for a number of medical device companies that have been acquired by major medical device corporations, including Medtronic.
A biomedical engineer graduate from Marquette University in Milwaukee, WI, Maureen contributed to the development of intellectual property for systems and methods related to prosthetic heart valve devices.
In her spare time, she is also a Court Appointed Special Advocate (CASA) – volunteering to enrich the lives of kids in foster care.
Laurent is a global medtech executive with talent for turning research projects into commercially viable companies.